Abstract:Epilepsy is a complex and multifaceted neurological disorder characterized by spontaneous and recurring seizures. It poses significant therapeutic challenges due to its diverse etiology and often-refractory nature. This comprehensive review highlights the pivotal role of AMP-activated protein kinase (AMPK), a key metabolic regulator involved in cellular energy homeostasis, which may be a promising therapeutic target for epilepsy. Current therapeutic strategies such as antiseizure medication (ASMs) can alleviate seizures (up to 70%). However, 30% of epileptic patients may develop refractory epilepsy. Due to the complicated nature of refractory epilepsy, other treatment options such as ketogenic dieting, adjunctive therapy, and in limited cases, surgical interventions are employed. These therapy options are only suitable for a select group of patients and have limitations of their own. Current treatment options for epilepsy need to be improved. Emerging evidence underscores a potential association between impaired AMPK functionality in the brain and the onset of epilepsy, prompting an in-depth examination of AMPK’s influence on neural excitability and ion channel regulation, both critical factors implicated in epileptic seizures. AMPK activation through agents such as metformin has shown promising antiepileptic effects in various preclinical and clinical settings. These effects are primarily mediated through the inhibition of the mTOR signaling pathway, activation of the AMPK-PI3K-c-Jun pathway, and stimulation of the PGC-1α pathway. Despite the potential of AMPK-targeted therapies, several aspects warrant further exploration, including the detailed mechanisms of AMPK’s role in different brain regions, the impact of AMPK under various conditional circumstances such as neural injury and zinc toxicity, the long-term safety and efficacy of chronic metformin use in epilepsy treatment, and the potential benefits of combination therapy involving AMPK activators. Moreover, the efficacy of AMPK activators in refractory epilepsy remains an open question. This review sets the stage for further research with the aim of enhancing our understanding of the role of AMPK in epilepsy, potentially leading to the development of more effective, AMPK-targeted therapeutic strategies for this challenging and debilitating disorder.

Role of the Mtor Signaling Pathway in Epilepsy

Mapping The Spatio-Temporal Pattern Of The Mammalian Target Of Rapamycin (Mtor) Activation In Temporal Lobe Epilepsy

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy

[Research Advances in the Role of Mtor Signaling Pathway in Autism Spectrum Disorder].

Phosphatidylinositol 3-Kinase/protein Kinase B/mammalian Target of Rapamycin Signaling Pathway and Epilepsy

Mechanistic target of rapamycin (mTOR) signaling in status epilepticus

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment

An insight into crosstalk among multiple signaling pathways contributing to epileptogenesis

The Coordination of mTOR Signaling and Non-Coding RNA in Regulating Epileptic Neuroinflammation

Abnormal increased mTOR signaling regulates seizure threshold in Dravet syndrome

Modeling mTORopathy-related epilepsy in cultured murine hippocampal neurons using the multi-electrode array

Inhibition of Mtor Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy

AMPK role in epilepsy: a promising therapeutic target?

Inhibition of Mtorc2 Improves Brain Injury in Epileptic Rats by Promoting Chaperone-Mediated Autophagy

Rapamycin Plays an Anti-Epileptic Role by Restoring Blood-Brain Barrier Dysfunction, Balancing T Cell Subsets and Inhibiting Neuronal Apoptosis

Rapamycin Suppresses the Recurrent Excitatory Circuits of Dentate Gyrus in A Mouse Model of Temporal Lobe Epilepsy

Modeling Epilepsy Using Human Induced Pluripotent Stem Cells-Derived Neuronal Cultures Carrying Mutations in Ion Channels and the Mechanistic Target of Rapamycin Pathway

A role of dentate gyrus mechanistic target of rapamycin activation in epileptogenesis in a mouse model of posttraumatic epilepsy

Research progress of dishevelled, Egl-10,and pleckstrin domain-containing protein 5 gene-related epilepsy

MicroRNAs dysregulation in epilepsy.